Subcutaneous Injection Sites: Rotation Guide
Location, rotation and skin changes
Abdomen, thigh or upper arm? The best starting point is the medicine’s own instructions. Even two under-skin treatments can allow different regions.
Within an allowed region, change the exact spot and avoid sore, red, bruised or hard skin. Switching locations is not a way to choose a stronger dose.
Same route. Different allowed regions.
| Product | Abdomen | Thigh | Upper arm |
|---|---|---|---|
| Wegovy | ✓ | ✓ | ✓ |
| EGRIFTA WR | ✓ | — | — |
Rotate the exact spot
Stay within the regions allowed by your own product’s instructions.
Where can I inject? Check the product first
These examples come from the Wegovy instructions and EGRIFTA WR label. They do not validate those sites for an unidentified research product.
A simple way to rotate your sites
A simple site-rotation record
-
Choose an allowed region
Use the locations in the instructions for the medicine and device you were prescribed.
-
Choose healthy skin
Avoid a spot that is sore, red, bruised, hard or otherwise excluded by the instructions.
-
Record the exact spot
Note the region and side so the next injection does not repeatedly use the same point.
A log can be as simple as “left abdomen, upper area” followed by a different permitted spot next time. A fixed calendar is less useful than checking how the skin actually looks and feels. Paper works. The injection-site tracker builds a printable rotation, and an iPhone app such as Brolic shows the last site used beside the schedule.
Under the skin is different from into muscle
The skin, underlying fat and deeper muscle are different compartments. A medicine labeled for subcutaneous use is intended for the fat layer. Changing to an intramuscular route can change absorption and is not an interchangeable technique.
Does belly versus thigh change results?
For Wegovy, the label reports similar semaglutide exposure across the abdomen, thigh and upper arm. An anecdote about less nausea in one area does not show that area produces better weight loss. Other products can behave differently; follow their own instructions.
Why rotation matters
Repeatedly using one small area can irritate tissue. Insulin research and injection guidance also describe thickened or abnormal fatty tissue from repeated injections, which can affect absorption. The exact risk should not be assumed identical for every peptide, but inspecting sites and following rotation instructions is useful practice.
Injection technique
Use the training and Instructions for Use for the specific device. Needle length, skin-fold technique, angle and hold time differ between pens and syringes; a universal “45 degrees” rule is inappropriate. Use a new sterile needle and syringe when those are required, and place used sharps in a suitable container. Do not share pens or reuse a syringe to enter a vial. CDC guidance
A lump, redness or pain: what next?
A small local reaction and a spreading infection are different problems. Increasing warmth, redness, pain, drainage or fever needs clinical assessment. A persistent hard lump should be assessed rather than repeatedly injected through. Breathing difficulty, throat swelling or faintness after administration is an emergency.
Common mistakes to avoid
- Reusing the same painless spot despite a lump beneath it.
- Assuming a different brand’s device instructions apply.
- Switching routes to change the plotted peak.
- Treating local swelling as proof of healing or a reason to inject closer to an injury.
Frequently asked questions
Where is the best place to inject peptides?
There is no universal best site. The approved product’s instructions and your clinician’s training determine suitable sites.
Does subcutaneous injection hurt?
Discomfort varies. Persistent or worsening pain needs assessment, rather than a different online technique.
How far apart should injection sites be?
Follow the product’s instructions about the navel, previous spots and affected skin; do not apply one distance to all devices and medicines.
Can I inject peptides into muscle instead?
Do not change a prescribed route without the prescriber. The route is part of the treatment, not just a convenience.
What do I do if I get a lump at the injection site?
Avoid that spot and have persistent or worsening changes assessed. Spreading redness, drainage or fever requires prompt care.
Sources and scope
- Wegovy prescribing information and device instructions.
- EGRIFTA WR product instructions.
- Frid et al., 2016 injection recommendations: diabetes/insulin context, not a trial of every peptide.
- CDC safe injection practices.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.